MedTrace Logo

Metabolomic Analysis of Lung Cancer

NCT00263731 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 249

Last updated 2022-05-09

No results posted yet for this study

Summary

The purpose of this study is to learn more about the metabolic properties of lung cancer cells.

Conditions

  • Carcinoma, Non-Small Cell Lung
  • Carcinoma, Small Cell Lung

Interventions

OTHER

13-C-glucose

10 grams of 13-C-glucose intravenously, as a 30-minute "piggyback" infusion, 2 to 6 hours prior to scheduled surgical resection of primary lung cancer.

Sponsors & Collaborators

  • James Graham Brown Cancer Center

    collaborator OTHER

  • University of Louisville

    lead OTHER

Principal Investigators

  • Donald M Miller, MD, PhD · James Graham Brown Cancer Center

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-12-31
Primary Completion
2020-09-24
Completion
2020-09-24

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00263731 on ClinicalTrials.gov